Jade Biosciences Inc. (JBIO)
NASDAQ: JBIO
· Real-Time Price · USD
9.79
-0.11 (-1.11%)
At close: Oct 16, 2025, 3:59 PM
10.04
2.61%
After-hours: Oct 16, 2025, 07:36 PM EDT
-1.11% (1D)
| Bid | 9.62 |
| Market Cap | 319.24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.42 |
| Volume | 153,822 |
| Avg. Volume (20D) | 117,310 |
| Open | 9.88 |
| Previous Close | 9.90 |
| Day's Range | 9.68 - 10.32 |
| 52-Week Range | 6.57 - 105.00 |
| Beta | 1.05 |
| Ex-Dividend Date | n/a |
About JBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for JBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+3.52%
Jade Biosciences shares are trading higher after B...
Unlock content with
Pro Subscription
4 months ago
+7.23%
Jade Biosciences shares are trading higher after the company a detailed preclinical characterization of JADE101, its anti-A Proliferation-Inducing Ligand (APRIL) monoclonal antibody, in development for IgA nephropathy